Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...
Chemistry World11d
Low concentration chemicals spur toxicological debate
Improved analytical techniques mean tiny amounts of endocrine disrupting compounds or PFAS can be found in many places. But ...
Le Lézard7d
Continuous Thermal Monitoring Market worth $1.49 billion by 2030 | MarketsandMarketstm
The global Continuous Thermal Monitoring Market is anticipated to grow from estimated USD 1.00 billion in 2024 to USD 1.49 billion by 2030, at a CAGR of 6.8% during the forecast period. The market is ...
Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...
The Associated Press on MSN10d
A US shutdown on foreign aid is hitting from Africa to Asia to Ukraine. Here's how
WASHINGTON — U.S-funded aid programs around the world have begun firing staff and shutting down or preparing to stop their ...
ophthalmologytimes4d
CHMP of the European Medicines Agency issues positive opinion on 2 aflibercept biosimilars
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
EU medicines agency quits X, moves to Bluesky
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...
The Straits Times11d
EU medicines agency quits X, moves to Bluesky
AMSTERDAM – The European Medicines Agency (EMA) said on Jan 27 that it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...